Skip to main content
. 2021 Oct 6;112(12):4819–4833. doi: 10.1111/cas.15139

FIGURE 2.

FIGURE 2

Therapeutic strategy in cholangiocarcinoma (CCA). GemCis, gemcitabine + cisplatin; GemOx, gemcitabine + oxaliplatin; GS, gemcitabine + S‐1; mFOLFOX, modified 5‐fluorouracil + oxaliplatin; PS, performance status